Evaluation of Carboplatin/Paclitaxel With and Without Trastuzumab (Herceptin) in Uterine Serous Cancer
Public ClinicalTrials.gov record NCT01367002. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Randomized Phase II Evaluation of Carboplatin/Paclitaxel With and Without Trastuzumab (Herceptin) in HER2/Neu+ Patients With Advance/Recurrent Uterine Serous Papillary Carcinoma
Study identification
- NCT ID
- NCT01367002
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Yale University
- Other
- Enrollment
- 61 participants
Conditions and interventions
Conditions
Interventions
- Carboplatin/Paclitaxel Drug
- Trastuzumab Drug
Drug
Eligibility (public fields only)
- Age range
- Not listed
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 31, 2011
- Primary completion
- Jun 29, 2022
- Completion
- Jun 29, 2022
- Last update posted
- May 16, 2023
2011 – 2022
United States locations
- U.S. sites
- 20
- U.S. states
- 11
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| St. Joseph's Hospital and Medical Center | Phoenix | Arizona | 85013 | — |
| University of Arizona Cancer Center | Tucson | Arizona | 85724 | — |
| John Muir Clinical Research Center | Concord | California | 94520 | — |
| Women's Cancer Research Foundation | Newport Beach | California | 92663 | — |
| Penrose St. Francis Hospital | Colorado Springs | Colorado | 80907 | — |
| Danbury Hospital | Danbury | Connecticut | 06810 | — |
| University of Connecticut Health Center | Farmington | Connecticut | 06030 | — |
| The Hospital of Central Connecticut | New Britain | Connecticut | 06050 | — |
| Smilow Cancer Hospital at Yale New Haven | New Haven | Connecticut | 06510 | — |
| The University of Chicago Medicine | Chicago | Illinois | 60637 | — |
| Greater Baltimore Medical Center | Baltimore | Maryland | 21204 | — |
| Walter Reed National Military Medical Center | Bethesda | Maryland | 20889-5600 | — |
| Holy Cross Hospital | Silver Spring | Maryland | 20910 | — |
| University of Maryland Medical Center | Silver Spring | Maryland | 20910 | — |
| Jersey Shore University Medical Center | Neptune City | New Jersey | 07753 | — |
| Montefiore Medical Center | The Bronx | New York | 10461 | — |
| Duke University School of Medicine | Durham | North Carolina | 27710 | — |
| Cleveland Clinic | Cleveland | Ohio | 44195 | — |
| The Ohio State University | Hilliard | Ohio | 43026 | — |
| University of Virginia | Charlottesville | Virginia | 22908 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01367002, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 16, 2023 · Synced May 4, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01367002 live on ClinicalTrials.gov.